These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 37428861)
1. Transcription factor ETV1-induced lncRNA MAFG-AS1 promotes migration, invasion, and epithelial-mesenchymal transition of pancreatic cancer cells by recruiting IGF2BP2 to stabilize ETV1 expression. Weng H; Feng W; Li F; Huang D; Lin L; Wang Z Growth Factors; 2023 Aug; 41(3):152-164. PubMed ID: 37428861 [TBL] [Abstract][Full Text] [Related]
3. LncRNA MAFG-AS1 facilitates the migration and invasion of NSCLC cell via sponging miR-339-5p from MMP15. Jia YC; Wang JY; Liu YY; Li B; Guo H; Zang AM Cell Biol Int; 2019 Apr; 43(4):384-393. PubMed ID: 30599080 [TBL] [Abstract][Full Text] [Related]
4. LncRNA MAFG-AS1 promotes the malignant phenotype of ovarian cancer by upregulating NFKB1-dependent IGF1. Bai Y; Ren C; Wang B; Xue J; Li F; Liu J; Yang L Cancer Gene Ther; 2022 Mar; 29(3-4):277-291. PubMed ID: 34035482 [TBL] [Abstract][Full Text] [Related]
5. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition. Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486 [TBL] [Abstract][Full Text] [Related]
6. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis. Li D; Zhong S; Zhu Z; Jiang X; Zhang J; Gu J; Chen F Pathobiology; 2020; 87(6):345-355. PubMed ID: 33238264 [TBL] [Abstract][Full Text] [Related]
7. LncRNA MAFG-AS1 promotes the aggressiveness of breast carcinoma through regulating miR-339-5p/MMP15. Li H; Zhang GY; Pan CH; Zhang XY; Su XY Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2838-2846. PubMed ID: 31002134 [TBL] [Abstract][Full Text] [Related]
8. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells. Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245 [TBL] [Abstract][Full Text] [Related]
9. LncRNA MAFG-AS1 Upregulates Polo-Like Kinase-1 by Sponging miR-505 to Promote Gastric Adenocarcinoma Cell Proliferation. Fu Y; Wen J; Li X; Gong M; Guo Z; Wang G Crit Rev Eukaryot Gene Expr; 2021; 31(5):27-32. PubMed ID: 34591387 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA MAFG-AS1: A promising therapeutic target for human cancers. Huang Z; Zhang M; Li J; Lou C Biomed Pharmacother; 2023 Jul; 163():114756. PubMed ID: 37105079 [TBL] [Abstract][Full Text] [Related]
11. Carcinogenic roles of MAFG-AS1 in human cancers. Ahmadi M; Morshedzadeh F; Ghaderian SMH; Mousavi P; Habibipour L; Peymani M; Abbaszadegan MR; Ghafouri-Fard S Clin Transl Oncol; 2024 Jan; 26(1):52-68. PubMed ID: 37351806 [TBL] [Abstract][Full Text] [Related]
12. LncRNA MAFG-AS1 is involved in human cancer progression. Li P; Ma X; Gu X Eur J Med Res; 2023 Nov; 28(1):497. PubMed ID: 37941063 [TBL] [Abstract][Full Text] [Related]
13. HBx-upregulated MAFG-AS1 promotes cell proliferation and migration of hepatoma cells by enhancing MAFG expression and stabilizing nonmuscle myosin IIA. Zhang F; Li Y; Gan L; Tong X; Qi D; Wang Q; Ye X FASEB J; 2021 May; 35(5):e21529. PubMed ID: 33813778 [TBL] [Abstract][Full Text] [Related]
14. LncRNA CERS6-AS1 promotes proliferation and metastasis through the upregulation of YWHAG and activation of ERK signaling in pancreatic cancer. Xu J; Wang J; He Z; Chen P; Jiang X; Chen Y; Liu X; Jiang J Cell Death Dis; 2021 Jun; 12(7):648. PubMed ID: 34168120 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression. Huang H; Yang C; Zhang Q; Zhuo T; Li X; Li N; Zhu L; Luo C; Gan J; Wu Y Bioengineered; 2022 Mar; 13(3):4964-4977. PubMed ID: 35164653 [TBL] [Abstract][Full Text] [Related]
16. LncRNA MAFG-AS1 boosts the proliferation of lung adenocarcinoma cells via regulating miR-744-5p/MAFG axis. Sui Y; Lin G; Zheng Y; Huang W Eur J Pharmacol; 2019 Sep; 859():172465. PubMed ID: 31211984 [TBL] [Abstract][Full Text] [Related]
17. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer. Yan H; Li H; Silva MA; Guan Y; Yang L; Zhu L; Zhang Z; Li G; Ren C J Exp Clin Cancer Res; 2019 Aug; 38(1):356. PubMed ID: 31412903 [TBL] [Abstract][Full Text] [Related]
18. A feedback loop between GATA2-AS1 and GATA2 promotes colorectal cancer cell proliferation, invasion, epithelial-mesenchymal transition and stemness via recruiting DDX3X. Pan Y; Zhu Y; Zhang J; Jin L; Cao P J Transl Med; 2022 Jun; 20(1):287. PubMed ID: 35752837 [TBL] [Abstract][Full Text] [Related]
19. LncRNA FAM83A-AS1 promotes epithelial-mesenchymal transition of pancreatic cancer cells via Hippo pathway. Wang H; Ding Y; Zhu Q; Yu Z; Wang Q; Gong A; Xu M Cell Cycle; 2023 Jun; 22(12):1514-1527. PubMed ID: 37245082 [TBL] [Abstract][Full Text] [Related]
20. LncRNA MAFG-AS1-induced acute myeloid leukemia development via modulating miR-147b/HOXA9. Yao Q; Zhang L; Liu Z; Yu L; Wang Y; Liu J; Wang Y Environ Sci Pollut Res Int; 2023 Feb; 30(7):19250-19258. PubMed ID: 36229729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]